Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Data availability
The TriNetX platform is a fully deidentified multinational, cloud-based database that adheres to all the relevant adheres to all standards laid out by Section §164,514(b) (1) of the Health Insurance Portability and Accountability Act (HIPPA) as well as ISO 27001:2013. Due to privacy restrictions, data from the TriNetX database is not publicly available. However, the population-level aggregate and deidentified data supporting the findings of this study are openly accessible upon reasonable request to the TriNetX administrators through their website (https://trinetx.com/) or by contacting the TriNetX administrators directly (Privacy@TriNetX.com). Alternatively, the corresponding author may also be contacted (doctoraga@gmail.com).
References
Zaki AM, Pasadhika S, Huang JC, Thomas AS, Burkholder BM, Lim LL, et al. Characterization of autoimmune eye disease in association with Down’s syndrome. Eye. 2024;38:386–92.
Hsu AY, Wang Y-H, Lin C-J, Li Y-L, Hsia N-Y, Lai C-T, et al. Assessing uveitis risk following pediatric Down Syndrome diagnosis: A TriNetX database study. Medicina. 2024;60:710.
Mathan JJ, Gokul A, Niederer RL, McGhee CNJ. Down syndrome and autoimmune eye disease. Eye. 2024;38:1024–5.
Funding
No funding was received for the publication of this article.
Author information
Authors and Affiliations
Contributions
AYH, YHW, CJL, NYH, CCC, CTL, HSC, YYT, JCCW: conceptualization and methodology; drafting, reviewing, and editing and approval of the final version.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hsu, A.Y., Wang, YH., Lin, CJ. et al. Reevaluating the link between Down Syndrome and uveitis. Eye 38, 2842–2843 (2024). https://doi.org/10.1038/s41433-024-03171-5
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41433-024-03171-5
